Among other things, March is Women’s History Month, giving us an opportunity to acknowledge and appreciate the contributions women have made to society at large while enhancing their own lives.
One such influential woman Contemporary OB/GYN® would like to thank and celebrate is Editorial Advisory Board member Laura Riley, MD, who was recently awarded the Society for Maternal-Fetal Medicine’s (SMFM) Lifetime Achievement Award at SMFM’s 42nd Annual Pregnancy Meeting held January 31 to February 5, 2022. This award was created to recognize physicians who have made significant contributions to the field of maternal-fetal medicine.
We asked Riley’s fellow board members about the significance of this award and the impact Riley’s work has had on this field. Here’s what some of them had to say:
“Laura has been an important and influential leader, expert, mentor, and researcher in maternal-fetal medicine and [obstetrics-gynecology] her entire life,” said Christian Pettker, MD. “Her lifetime experience and achievement, and her stature and credibility were critical to disseminate accurate information, mobilize better resources and attention, and correct the major gaps and disenfranchisement affecting pregnant people affected and at risk for COVID-19. It is clear that, although this is a lifetime achievement award, her work is nowhere near complete.”
Sarah Kilpatrick, MD, added, “Dr Riley is a fantastic choice for the SMFM Lifetime Achievement Award. She has contributed across our field and within SMFM from mentor to presenter to organizer to leader.”
Again, we thank Riley for all her contributions to both maternal-fetal medicine and Contemporary OB/GYN®.
__
Mike Hennessy Jr
President and CEO, MJH Life Sciences®
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More